[

"/404.html","/","/archive-layout-with-content/","/awards/","/categories/","/collection-archive/","/contact/","/interests/","/markdown/","/media/","/non-menu-page/","/page-archive/","/portfolio/","/privacy/","/publications/","/tags/","/talkmap.html","/talks/","/teaching/","/terms/","/year-archive/","/publication/2021-10-01-arab-transplant-bibliometric.html","/publication/2021-10-01-arab-transplant-bibliometric/","/publication/2022-04-23-drug-repurposing-colon-cancer.html","/publication/2022-04-23-drug-repurposing-colon-cancer/","/publication/2022-07-13-hypertension-kap-lebanon.html","/publication/2022-07-13-hypertension-kap-lebanon/","/publication/2022-07-29-cvd-kap-lebanon.html","/publication/2022-07-29-cvd-kap-lebanon/","/publication/2022-11-17-arab-cancer-research-bibliometric.html","/publication/2022-11-17-arab-cancer-research-bibliometric/","/publication/2024-01-05-tert-promoter-mutations-race-sex.html","/publication/2024-01-05-tert-promoter-mutations-race-sex/","/publication/2024-10-03-liquid-biopsy-rcc.html","/publication/2024-10-03-liquid-biopsy-rcc/","/publication/2025-02-01-nk-cell-dysfunction-ccrcc.html","/publication/2025-02-01-nk-cell-dysfunction-ccrcc/","/publication/2025-02-10-axl-signaling-review.html","/publication/2025-02-10-axl-signaling-review/","/publication/2025-05-01-kim1-prognostic-rcc.html","/publication/2025-05-01-kim1-prognostic-rcc/","/publication/2025-06-02-ici-preexisting-neurologic-autoimmune.html","/publication/2025-06-02-ici-preexisting-neurologic-autoimmune/","/publication/2025-08-01-comorbidity-immunotherapy-mrcc.html","/publication/2025-08-01-comorbidity-immunotherapy-mrcc/","/publication/2025-08-10-chromophobe-rcc-antitumor-immunity.html","/publication/2025-08-10-chromophobe-rcc-antitumor-immunity/","/publication/2025-08-18-axl-cmet-resistance-rcc.html","/publication/2025-08-18-axl-cmet-resistance-rcc/","/publication/2025-11-04-mlh1-mmr-ici-ccrcc.html","/publication/2025-11-04-mlh1-mmr-ici-ccrcc/","/publication/2025-11-14-slc1a1-nat-comm.html","/publication/2025-11-14-slc1a1-nat-comm/","/publication/2025-11-28-hif2-cachexia-rcc.html","/publication/2025-11-28-hif2-cachexia-rcc/","/publications/2026-01-07-nature-medicine-smadcam1-mrcc.html","/publications/2026-01-12-clinical-cancer-research-nf2-merlin-rcc.html","/publication/2026-04-01-jnci-tdxd-breast-cancer.html","/publication/2026-04-01-jnci-tdxd-breast-cancer/","/publication/2026-04-22-img-representation-asco.html","/publication/2026-04-22-img-representation-asco/","/publication/2026-04-28-nrco-hif2.html","/publication/2026-04-28-nrco-hif2/","/publication/2026-06-25-nat-med-histidine.html","/publication/2026-06-25-nat-med-histidine/","/publication/2026-08-06-oncologist-rcc-lag3.html","/publication/2026-08-06-oncologist-rcc-lag3/","/publication/2026-10-06-pharmacologic-hif2-inhibition-t-cell-function.html","/publication/2026-10-06-pharmacologic-hif2-inhibition-t-cell-function/","/publication/2026-10-19-validation-intermediate-endpoints-real-world-data.html","/publication/2026-10-19-validation-intermediate-endpoints-real-world-data/","/md/","/markdown.html","/nmp/","/nmp.html","/wordpress/blog-posts/","/markdown_generator/"
,"/media/2024-02-01-onkologi-immune-signatures/","/media/2024-05-15-asco-daily-ici-rechallenge/","/media/2024-05-25-oncodaily-ici-rechallenge/","/media/2024-07-19-onclive-axl-cmet/","/media/2024-09-14-ecancer-erbb2/","/media/2024-10-04-onclive-erbb2-amplification/","/media/2025-05-30-guoncology-elevated-kim1/","/media/2025-06-11-guoncology-kim1-biology/","/media/2025-07-02-onclive-low-kim1/","/media/2025-07-17-onclive-kim1-role/","/media/2025-10-18-vj-oncology-madcam1/","/media/2025-11-11-urology-times-madcam1/","/portfolio/portfolio-1/","/portfolio/portfolio-2/","/posts/2012/08/blog-post-4/","/posts/2012/08/blog-post-1/","/posts/2013/08/blog-post-2/","/posts/2014/08/blog-post-3/","/publications/2021-10-01-arab-transplant-bibliometric/","/publications/2022-04-23-drug-repurposing-colon-cancer/","/publications/2022-07-13-hypertension-kap-lebanon/","/publications/2022-07-29-cvd-kap-lebanon/","/publications/2022-11-17-arab-cancer-research-bibliometric/","/publications/2024-01-05-tert-promoter-mutations-race-sex/","/publications/2024-10-03-liquid-biopsy-rcc/","/publications/2025-02-01-nk-cell-dysfunction-ccrcc/","/publications/2025-02-10-axl-signaling-review/","/publications/2025-05-01-kim1-prognostic-rcc/","/publications/2025-06-02-ici-preexisting-neurologic-autoimmune/","/publications/2025-08-01-comorbidity-immunotherapy-mrcc/","/publications/2025-08-10-chromophobe-rcc-antitumor-immunity/","/publications/2025-08-18-axl-cmet-resistance-rcc/","/publications/2025-11-04-mlh1-mmr-ici-ccrcc/","/publications/2025-11-14-slc1a1-nat-comm/","/publications/2025-11-28-hif2-cachexia-rcc/","/publications/2026-01-07-nature-medicine-smadcam1-mrcc/","/publications/2026-01-12-clinical-cancer-research-nf2-merlin-rcc/","/publications/2026-04-01-jnci-tdxd-breast-cancer/","/publications/2026-04-22-img-representation-asco/","/publications/2026-04-28-nrco-hif2/","/publications/2026-06-25-nat-med-histidine/","/publications/2026-08-06-oncologist-rcc-lag3/","/publications/2026-10-06-pharmacologic-hif2-inhibition-t-cell-function/","/publications/2026-10-19-validation-intermediate-endpoints-real-world-data/","/talks/2021-07-14-cvd-covid-lebanon-oral","/talks/2024-01-24-onclive-immune-signatures-oral","/talks/2024-05-24-asco-erbb2-urothelial-poster","/talks/2024-07-11-kcrs-axl-cmet-poster","/talks/2024-09-14-esmo-erbb2-amplifications-poster","/talks/2025-02-18-asco-gu-kim1-javelin-poster","/talks/2025-02-25-onclive-kim1-oral","/talks/2025-05-22-sitc-biomarkers-oral","/talks/2025-05-28-asco-kim1-integrative-poster","/talks/2025-07-18-kcrs-kim1-integrative-oral","/talks/2025-09-07-sitc-irae-adc-poster","/talks/2025-10-17-madcam1-esmo-oral","/talks/2026-02-28-rwe-surrogates-gu-asco","/talks/2026-06-01-multiaxis-asco","/teaching/2014-spring-teaching-1","/teaching/2015-spring-teaching-1"
]